Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers

PURPOSE: Paclitaxel is a cytotoxic chemotherapy commonly used in patients with triple negative breast cancer (TNBC); however, the resistance to paclitaxel is a cause of poor response in the patients. The aim of this study was to examine the role of protein phosphatase 1H (PPM1H) in paclitaxel resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Hur, Saem, Kim, Ju Hee, Yun, Jihui, Ju, Young Wook, Han, Jong Min, Heo, Woohang, Kim, Kwangsoo, Jeong, Kyeonghun, Lee, Han-Byoel, Han, Wonshik, Noh, Dong-Young, Kim, Jong-Il, Moon, Hyeong-Gon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192749/
https://www.ncbi.nlm.nih.gov/pubmed/32395375
http://dx.doi.org/10.4048/jbc.2020.23.e20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192749/
https://www.ncbi.nlm.nih.gov/pubmed/32395375
http://dx.doi.org/10.4048/jbc.2020.23.e20

Ejemplares similares